High rates of scanning with Abbott′s FreeStyle Libre system linked to improved glucose control in diabetes patients
Abbott today announced the results of real-world use data showing that people who scan more frequently using Abbott′s FreeStyle® Libre system spend less time in hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) while having improved average glucose levels. According to the data, more than 50,000 people with diabetes using the FreeStyle Libre system checked their glucose levels an average of 16 times per day—which is three times more than the minimum recommended U.S. and European guidelines for testing with the traditional fingerstick technique. The data show that higher rates of scanning with the FreeStyle Libre system were found to be strongly associated with improved glucose control.
"There is now substantial evidence from both real-world usage and clinical studies that reaffirms the powerful impact of the FreeStyle Libre system," said Jared Watkin, senior vice president, Diabetes Care, Abbott. "The FreeStyle Libre system is changing how diabetes has been managed for decades, with one simple swipe. Most importantly, we’re doing that by empowering patients with the information that they need to take action themselves, helping people living with diabetes live fuller, healthier lives."
Abbott′s FreeStyle Libre system consists of a small, round sensor worn on the back of the upper arm for up to 14 days, which measures glucose every minute in interstitial fluid through a small filament that is inserted just under the skin and held in place with a small adhesive pad.
The FreeStyle Libre reader is scanned over the sensor to get a glucose result in les Continue reading